The Embryonic Stem Cell Microenvironment Inhibits Mouse Glioma Cell Proliferation by Regulating the PI3K/AKT Pathway

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35116278

Authors

Xiongjun He

Jiahui Liu

Xiaoran Wang

Tengfei Liu

Liu Yang

Chaoyang Li

Chenjie Wang

Ying Liu

Xuan Sang

Zhichong Wang

Xiaohe Lu

Affiliations

Soon will be listed here.

Abstract

Background: Glioblastoma multiforme (GBM) is the most common malignant tumor of the central nervous system, accounting for 48.6% of malignant tumors. The current standard treatment plan includes the widest range of safe surgical resection, supplemented by local brain radiotherapy and temozolomide concurrent chemotherapy; this can cause serious side effects. Even so, the median survival time of GBM patients is only 8 months, and the 5-year survival rate is only 5.5%. It is imminent to find new treatments. Early studies have shown that chicken and zebrafish embryos can reprogram cancer cells into a non-tumorigenic phenotype through the embryonic microenvironment. However, the effect of embryonic stem cell microenvironment on GBM and its possible mechanism are not clear.

Methods: In this study, the glioblastoma cell line, U118, in the brain was investigated. There were four experimental groups: GB, GE, GA and GT. U118 cells were harvested after culturing for 72 hours. Cell proliferation, apoptosis, reactive oxygen species (ROS) were examined using vasculogenic mimicry assays, quantitative real-time polymerase chain reaction (QRT-PCR), western blotting (WB) and flow cytometry. The differences in the biological function of U118 cells and the PI3K/protein kinase B (AKT) signaling pathway were compared between the groups.

Results: Compared with the GB control group, the GE co-culture group and GT chemotherapy group showed reduced cell proliferation, increased apoptosis, increased ROS, as well as decreased or inhibited vasculogenic mimicry. Expressions of cyclin B1 and cyclin D1 were also notably reduced, while that of Bax, Bcl-2, p53, Caspase-3, GSK-3β, p21, and p27 were significantly increased. Moreover, the expression of PI3K, AKT, and mTOR were markedly decreased, whereas expression of PTEN increased considerably. Also, the expression of positive regulatory factors significantly increased, however negative regulatory factors decreased in the GA group compared to the GE group.

Conclusions: The ESC microenvironment reverses glioma malignancy, partially via inhibition of the PI3K signaling pathway. Our study may have a significant impact and important clinical implications for cell therapy in the treatment of glioma.

Citing Articles

Human embryonic stem cells exert antitumor effects on prostate cancer cells in a co-culture microenvironment.

Yang X, Lu Y, Kuang Q, Wu Y, Tan X, Lan J Front Oncol. 2023; 13:1164250.

PMID: 37313467 PMC: 10258316. DOI: 10.3389/fonc.2023.1164250.

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.

Attia N, Mashal M, Pemminati S, Omole A, Edmondson C, Jones W Cells. 2022; 11(1).

PMID: 35011678 PMC: 8750228. DOI: 10.3390/cells11010116.

References

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Astigiano S, Damonte P, Fossati S, Boni L, Barbieri O . Fate of embryonal carcinoma cells injected into postimplantation mouse embryos. Differentiation. 2005; 73(9-10):484-90. DOI: 10.1111/j.1432-0436.2005.00043.x. View

Menon L, Kelly K, Yang H, Kim S, Black P, Carroll R . Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells. 2009; 27(9):2320-30. DOI: 10.1002/stem.136. View

Gerschenson M, Graves K, Carson S, Wells R, Pierce G . Regulation of melanoma by the embryonic skin. Proc Natl Acad Sci U S A. 1986; 83(19):7307-10. PMC: 386705. DOI: 10.1073/pnas.83.19.7307. View

Lee L, Seftor E, Bonde G, Cornell R, Hendrix M . The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn. 2005; 233(4):1560-70. DOI: 10.1002/dvdy.20471. View

Shi Y, Du L, Lin L, Wang Y . Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2016; 16(1):35-52. DOI: 10.1038/nrd.2016.193. View

Balyasnikova I, Ferguson S, Han Y, Liu F, Lesniak M . Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett. 2011; 310(2):148-59. PMC: 3159776. DOI: 10.1016/j.canlet.2011.06.029. View

Cucina A, Biava P, Danselmi F, Coluccia P, Conti F, Di Clemente R . Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis. 2006; 11(9):1617-28. DOI: 10.1007/s10495-006-8895-4. View

Wang C, Wang X, Liu J, Huang Z, Li C, Liu Y . Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway. Cancer Med. 2019; 8(9):4265-4277. PMC: 6675703. DOI: 10.1002/cam4.2207. View

10.

Park S, Kim S, Kim K, Yu S, Choi H, Kim Y . Toyocamycin induces apoptosis via the crosstalk between reactive oxygen species and p38/ERK MAPKs signaling pathway in human prostate cancer PC-3 cells. Pharmacol Rep. 2016; 69(1):90-96. DOI: 10.1016/j.pharep.2016.10.014. View

11.

Pyko I, Nakada M, Sabit H, Teng L, Furuyama N, Hayashi Y . Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling. Carcinogenesis. 2013; 34(10):2206-17. DOI: 10.1093/carcin/bgt182. View

12.

Jiang G, Wei Z, Pei D, Xin Y, Liu Y, Zheng J . A novel approach to overcome temozolomide resistance in glioma and melanoma: Inactivation of MGMT by gene therapy. Biochem Biophys Res Commun. 2011; 406(3):311-4. DOI: 10.1016/j.bbrc.2011.02.042. View

13.

Zhou C, Huang Z, Li P, Li W, Liu Y, Li C . Safety and efficacy of embryonic stem cell microenvironment in a leukemia mouse model. Stem Cells Dev. 2014; 23(15):1741-54. DOI: 10.1089/scd.2013.0585. View

14.

DeGregori J . Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments. Cancer Res. 2017; 77(22):6065-6068. PMC: 5690828. DOI: 10.1158/0008-5472.CAN-17-1207. View

15.

Thorpe L, Yuzugullu H, Zhao J . PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer. 2014; 15(1):7-24. PMC: 4384662. DOI: 10.1038/nrc3860. View

16.

Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

17.

Kulesa P, Kasemeier-Kulesa J, Teddy J, Margaryan N, Seftor E, Seftor R . Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A. 2006; 103(10):3752-7. PMC: 1450149. DOI: 10.1073/pnas.0506977103. View

18.

Liu J, Huang Z, Yang L, Wang X, Wang S, Li C . Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma. Theranostics. 2019; 9(16):4764-4778. PMC: 6643444. DOI: 10.7150/thno.33139. View

19.

Postovit L, Margaryan N, Seftor E, Kirschmann D, Lipavsky A, Wheaton W . Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A. 2008; 105(11):4329-34. PMC: 2393795. DOI: 10.1073/pnas.0800467105. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View